Pharma-Bio Serv (OTCMKTS:PBSV) Shares Pass Below 200-Day Moving Average of $0.92

Pharma-Bio Serv, Inc. (OTCMKTS:PBSVGet Free Report) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.92 and traded as low as $0.65. Pharma-Bio Serv shares last traded at $0.75, with a volume of 14,159 shares.

Pharma-Bio Serv Stock Performance

The business has a fifty day moving average of $0.87 and a 200-day moving average of $0.92. The firm has a market cap of $18.37 million, a PE ratio of 26.68 and a beta of 0.51.

Pharma-Bio Serv (OTCMKTS:PBSVGet Free Report) last posted its earnings results on Monday, March 18th. The company reported ($0.01) earnings per share for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.03). Pharma-Bio Serv had a return on equity of 3.95% and a net margin of 4.05%. The firm had revenue of $2.38 million for the quarter, compared to the consensus estimate of $5.00 million. On average, equities analysts forecast that Pharma-Bio Serv, Inc. will post 0.08 EPS for the current year.

Pharma-Bio Serv Company Profile

(Get Free Report)

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.

Featured Articles

Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.